The search strategy was: (Obese Fertile Men OR Functional hypogonadism OR "Diabetes Mellitus, Type 2"[Mesh] OR "Erectile Dysfunction"[Mesh]) AND ("Glucagon-Like Peptide-1 Receptor Agonists"[Mesh] OR semaglutide OR liraglutide OR dulaglutide OR exenatide OR lixisenatide OR tirzepatide) AND (Before treatment OR "Testosterone"[Mesh])
The science was great, but it presented some practical issues for patients
Weve shown these cells reach the brain intact. Two pathways make this possible: The Olfactory Pathway: Provides rapid, direct access to the brain through extracellular transport, with therapeutic agents reaching the olfactory bulb within minutes of administration
Outcomes and considerations on this page are drawn from the following peer-reviewed publications and regulatory registries
The bigger risk after stopping is regaining fat, not losing more muscle
"We're also hearing about clinicians prescribing for that reason," he says